Susquehanna International Group’s Akcea Therapeutics Inc AKCA Stock Holding History

Susquehanna International Group’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-33,430	Closed	-$516K	–	11382
2020 Q1	$478K	Sell	33,430 -27,164	-45%	-$446K	﹤0.01%	7038
2019 Q4	$1.03M	Buy	+60,594	New	+$1.13M	﹤0.01%	5470
2019 Q3	–	Sell	-17,421	Closed	-$371K	–	11140
2019 Q2	$409K	Buy	+17,421	New	+$430K	﹤0.01%	7690

Susquehanna International Group's AKCA Position: Q2 2020 in Review

Susquehanna International Group sold out of Akcea Therapeutics Inc (AKCA) in Q2 2020, closing a stake of 33,430 shares — an estimated $516K sold.

Susquehanna International Group first reported a position in AKCA in Q2 2019 and held it in 3 quarters. The position peaked at $1.03M in Q4 2019. 84 funds tracked by Wall St. Rank hold AKCA as of Q2 2020.

Susquehanna International Group reported no remaining Akcea Therapeutics Inc position as of Q2 2020 after selling out during the quarter.
Susquehanna International Group sold 33,430 Akcea Therapeutics Inc shares in Q2 2020, an estimated $516K.
Susquehanna International Group first reported a position in Akcea Therapeutics Inc in Q2 2019 and held it in 3 quarters.
Susquehanna International Group's Akcea Therapeutics Inc position peaked at $1.03M in Q4 2019.
84 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q2 2020.

Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.